
NearWave
NearWave is a YC Winter 2022 (W22) company. Based in Austin, TX, USA; South Bend, IN, USA. Team of 3.
About NearWave
Summary
NearWave builds a handheld near-infrared spectroscopy device that measures tissue biomarkers, including oxygen saturation and hemoglobin concentrations, at depth without ionizing radiation. Oncologists use it to guide breast cancer treatment selection, replacing a trial-and-error approach that can expose patients to months of ineffective therapy and its side effects.
Go-to-market
The device is sold into clinical and research settings, with physicians as the primary users; it is currently cleared for investigational use only.
From the Y Combinator listing
Helping physicians select the right therapy for breast cancer patients
NearWave makes a handheld imaging device that helps physicians select the right therapy for their breast cancer patients. This prevents patients from suffering through months of side effects caused by unsuccessful treatments.
Facts
- Healthcare / Healthcare -> Medical Devices
- Austin, TX, USA; South Bend, IN, USA
- 3
- Active
- Early
Founders (1)
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works